Hangzhou Diagens Biotechnology Co., Ltd. (HKG:2526)

HKG:2526 Revenue

Hangzhou Diagens Biotechnology had revenue of 54.35M CNY in the quarter ending June 30, 2026, with 21.03% growth. This brings the company's total for the last twelve months to 183.31M. In the year 2025, Hangzhou Diagens Biotechnology had annual revenue of 164.42M with 133.72% growth. That makes Hangzhou Diagens Biotechnology the 32,035th largest company in the world by revenue and 1,919th in Hong Kong.

• Revenue (ttm): 183.31M CNY
• Revenue Growth: +133.72%
• P/S Ratio: 94.07
• Revenue / Employee: 1.05M CNY
• Employees: 174
• Market Cap: 18.26B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	164.42M	94.07M	133.72%
Dec 31, 2024	70.35M	17.51M	33.13%
Dec 31, 2023	52.84M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error